ICD-10-CM/PCS MS-DRG v37.1 R1 Definitions Manual
![Previous Page [Alt-p]](bakpg.png){kind=small}
![Up a level [Alt-u]](uptop.png){kind=small}
![Next Page [Alt-n]](fwdpg.png){kind=small}
ICD-10-CM/PCS MS-DRG v37.1 R1 Definitions Manual |
||||
| Skip to content | |
|
|
| MDC 21 Injuries, Poisonings & Toxic Effects of Drugs |
| Other O.R. Procedures for Injuries |
| Page 74 of 74 |
OPERATING ROOM PROCEDURES (continued)
0016070 00DH3ZZ 00RN0JZ 00XL4ZK 01NG3ZZ 021R4JA 02RP0JZ 03180JV 037P45Z 03LA4DZ 03S40ZZ 03VL3DZ 041F4AK 047J3D1 04L64ZZ 04RF0JZ 04V40DZ 05BS3ZZ 05P34MZ 05UR4JZ 06L80DZ 06UC07Z 07L80DZ 07V20DZ 08CF3ZZ 08UG3KZ 09UM0JZ 0BR90JZ 0CRB0JZ 0D180ZN 0D1E8ZP 0D984ZZ 0DLQ0DZ 0DRR4JZ 0DUU0KZ 0DWD43Z 0FCC7ZZ 0FU64JZ 0HHX01Z 0JR137Z 0K8J0ZZ 0KPY0KZ 0KU80KZ 0L9Q4ZZ 0LR907Z 0LX04ZZ 0MD04ZZ 0NBC0ZZ 0NS734Z 0PCF3ZZ 0PP737Z 0PS534Z 0Q844ZZ 0QHF05Z 0QPH47Z 0QS73BZ 0QUN37Z 0RG80J1 0RPK03Z 0RWG07Z 0SG10JJ 0SJD0ZZ 0SPQ0KZ 0SWA4JZ 0T164J6 0TLB4ZZ 0TVD3CZ 0UU777Z 0VUP87Z 0WCP3ZZ 0WWG43Z 0XQ5XZZ 0Y6C0Z2 0YUL0JZ
| 0YUL0JZ | Supplement Left Ankle Region with Synthetic Substitute, Open Approach |
| 0YUL0KZ | Supplement Left Ankle Region with Nonautologous Tissue Substitute, Open Approach |
| 0YUL47Z | Supplement Left Ankle Region with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUL4JZ | Supplement Left Ankle Region with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUL4KZ | Supplement Left Ankle Region with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUM07Z | Supplement Right Foot with Autologous Tissue Substitute, Open Approach |
| 0YUM0JZ | Supplement Right Foot with Synthetic Substitute, Open Approach |
| 0YUM0KZ | Supplement Right Foot with Nonautologous Tissue Substitute, Open Approach |
| 0YUM47Z | Supplement Right Foot with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUM4JZ | Supplement Right Foot with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUM4KZ | Supplement Right Foot with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUN07Z | Supplement Left Foot with Autologous Tissue Substitute, Open Approach |
| 0YUN0JZ | Supplement Left Foot with Synthetic Substitute, Open Approach |
| 0YUN0KZ | Supplement Left Foot with Nonautologous Tissue Substitute, Open Approach |
| 0YUN47Z | Supplement Left Foot with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUN4JZ | Supplement Left Foot with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUN4KZ | Supplement Left Foot with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUP07Z | Supplement Right 1st Toe with Autologous Tissue Substitute, Open Approach |
| 0YUP0JZ | Supplement Right 1st Toe with Synthetic Substitute, Open Approach |
| 0YUP0KZ | Supplement Right 1st Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUP47Z | Supplement Right 1st Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUP4JZ | Supplement Right 1st Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUP4KZ | Supplement Right 1st Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUQ07Z | Supplement Left 1st Toe with Autologous Tissue Substitute, Open Approach |
| 0YUQ0JZ | Supplement Left 1st Toe with Synthetic Substitute, Open Approach |
| 0YUQ0KZ | Supplement Left 1st Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUQ47Z | Supplement Left 1st Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUQ4JZ | Supplement Left 1st Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUQ4KZ | Supplement Left 1st Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUR07Z | Supplement Right 2nd Toe with Autologous Tissue Substitute, Open Approach |
| 0YUR0JZ | Supplement Right 2nd Toe with Synthetic Substitute, Open Approach |
| 0YUR0KZ | Supplement Right 2nd Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUR47Z | Supplement Right 2nd Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUR4JZ | Supplement Right 2nd Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUR4KZ | Supplement Right 2nd Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUS07Z | Supplement Left 2nd Toe with Autologous Tissue Substitute, Open Approach |
| 0YUS0JZ | Supplement Left 2nd Toe with Synthetic Substitute, Open Approach |
| 0YUS0KZ | Supplement Left 2nd Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUS47Z | Supplement Left 2nd Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUS4JZ | Supplement Left 2nd Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUS4KZ | Supplement Left 2nd Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUT07Z | Supplement Right 3rd Toe with Autologous Tissue Substitute, Open Approach |
| 0YUT0JZ | Supplement Right 3rd Toe with Synthetic Substitute, Open Approach |
| 0YUT0KZ | Supplement Right 3rd Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUT47Z | Supplement Right 3rd Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUT4JZ | Supplement Right 3rd Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUT4KZ | Supplement Right 3rd Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUU07Z | Supplement Left 3rd Toe with Autologous Tissue Substitute, Open Approach |
| 0YUU0JZ | Supplement Left 3rd Toe with Synthetic Substitute, Open Approach |
| 0YUU0KZ | Supplement Left 3rd Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUU47Z | Supplement Left 3rd Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUU4JZ | Supplement Left 3rd Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUU4KZ | Supplement Left 3rd Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUV07Z | Supplement Right 4th Toe with Autologous Tissue Substitute, Open Approach |
| 0YUV0JZ | Supplement Right 4th Toe with Synthetic Substitute, Open Approach |
| 0YUV0KZ | Supplement Right 4th Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUV47Z | Supplement Right 4th Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUV4JZ | Supplement Right 4th Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUV4KZ | Supplement Right 4th Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUW07Z | Supplement Left 4th Toe with Autologous Tissue Substitute, Open Approach |
| 0YUW0JZ | Supplement Left 4th Toe with Synthetic Substitute, Open Approach |
| 0YUW0KZ | Supplement Left 4th Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUW47Z | Supplement Left 4th Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUW4JZ | Supplement Left 4th Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUW4KZ | Supplement Left 4th Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUX07Z | Supplement Right 5th Toe with Autologous Tissue Substitute, Open Approach |
| 0YUX0JZ | Supplement Right 5th Toe with Synthetic Substitute, Open Approach |
| 0YUX0KZ | Supplement Right 5th Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUX47Z | Supplement Right 5th Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUX4JZ | Supplement Right 5th Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUX4KZ | Supplement Right 5th Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUY07Z | Supplement Left 5th Toe with Autologous Tissue Substitute, Open Approach |
| 0YUY0JZ | Supplement Left 5th Toe with Synthetic Substitute, Open Approach |
| 0YUY0KZ | Supplement Left 5th Toe with Nonautologous Tissue Substitute, Open Approach |
| 0YUY47Z | Supplement Left 5th Toe with Autologous Tissue Substitute, Percutaneous Endoscopic Approach |
| 0YUY4JZ | Supplement Left 5th Toe with Synthetic Substitute, Percutaneous Endoscopic Approach |
| 0YUY4KZ | Supplement Left 5th Toe with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach |
| X27H385 | Dilation of Right Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 |
| X27H395 | Dilation of Right Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27H3B5 | Dilation of Right Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27H3C5 | Dilation of Right Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27J385 | Dilation of Left Femoral Artery with Sustained Release Drug-eluting Intraluminal Device, Percutaneous Approach, New Technology Group 5 |
| X27J395 | Dilation of Left Femoral Artery with Two Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27J3B5 | Dilation of Left Femoral Artery with Three Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| X27J3C5 | Dilation of Left Femoral Artery with Four or More Sustained Release Drug-eluting Intraluminal Devices, Percutaneous Approach, New Technology Group 5 |
| XNS0032 | Reposition of Lumbar Vertebra using Magnetically Controlled Growth Rod(s), Open Approach, New Technology Group 2 |
| XNS0332 | Reposition of Lumbar Vertebra using Magnetically Controlled Growth Rod(s), Percutaneous Approach, New Technology Group 2 |
| XNS3032 | Reposition of Cervical Vertebra using Magnetically Controlled Growth Rod(s), Open Approach, New Technology Group 2 |
| XNS3332 | Reposition of Cervical Vertebra using Magnetically Controlled Growth Rod(s), Percutaneous Approach, New Technology Group 2 |
| XNS4032 | Reposition of Thoracic Vertebra using Magnetically Controlled Growth Rod(s), Open Approach, New Technology Group 2 |
| XNS4332 | Reposition of Thoracic Vertebra using Magnetically Controlled Growth Rod(s), Percutaneous Approach, New Technology Group 2 |
| XRG0092 | Fusion of Occipital-cervical Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRG00F3 | Fusion of Occipital-cervical Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRG1092 | Fusion of Cervical Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRG10F3 | Fusion of Cervical Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRG2092 | Fusion of 2 or more Cervical Vertebral Joints using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRG20F3 | Fusion of 2 or more Cervical Vertebral Joints using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRG4092 | Fusion of Cervicothoracic Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRG40F3 | Fusion of Cervicothoracic Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRG6092 | Fusion of Thoracic Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRG60F3 | Fusion of Thoracic Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRG7092 | Fusion of 2 to 7 Thoracic Vertebral Joints using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRG70F3 | Fusion of 2 to 7 Thoracic Vertebral Joints using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRG8092 | Fusion of 8 or more Thoracic Vertebral Joints using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRG80F3 | Fusion of 8 or more Thoracic Vertebral Joints using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRGA092 | Fusion of Thoracolumbar Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRGA0F3 | Fusion of Thoracolumbar Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRGB092 | Fusion of Lumbar Vertebral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRGB0F3 | Fusion of Lumbar Vertebral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRGC092 | Fusion of 2 or more Lumbar Vertebral Joints using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRGC0F3 | Fusion of 2 or more Lumbar Vertebral Joints using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
| XRGD092 | Fusion of Lumbosacral Joint using Nanotextured Surface Interbody Fusion Device, Open Approach, New Technology Group 2 |
| XRGD0F3 | Fusion of Lumbosacral Joint using Radiolucent Porous Interbody Fusion Device, Open Approach, New Technology Group 3 |
NON-OPERATING ROOM PROCEDURES
| 02H63JZ* | Insertion of Pacemaker Lead into Right Atrium, Percutaneous Approach |
| 02H73JZ* | Insertion of Pacemaker Lead into Left Atrium, Percutaneous Approach |
| 02HK3JZ* | Insertion of Pacemaker Lead into Right Ventricle, Percutaneous Approach |
| 02HL3JZ* | Insertion of Pacemaker Lead into Left Ventricle, Percutaneous Approach |
|
Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244 23 Mar 2020 12:40:01 CMS, code-revision=249, description-revision=1272 |